TIFFANY JOHNSON: Open Payments
NPI 1588603591 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 37 payments from 14 companies in 2025. Trend: 2023 $1,597 · 2024 $1,220 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Baxter Healthcare | 1 | $160 |
| Axsome Therapeutics, Inc. | 4 | $159 |
| Alkermes, Inc. | 8 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| ABBVIE INC. | 3 | $55 |
| Stryker Corporation | 1 | $34 |
Products named: STARLING SYSTEM, Auvelity, ARISTADA, CAPLYTA, AUSTEDO XR, REXULTI, COBENFY, FANAPT.
Industry payments across VA — which companies pay providers there.
